David Lane

David Lane, 60, joined Ludwig Institute for Cancer Research as Scientific Director. He will retain his existing appointment as Chief Scientist at Singapore’s Agency for Science, Technology and Research (A*STAR) and share his time between Ludwig and A*STAR.

In this role, Professor Sir David Lane will lead Ludwig’s global cancer research effort, fostering collaboration, coordinating research activities and representing its international network of leading scientists.

Professor Lane has directed scientific programs at Imperial College, ICRF Laboratories at Clare Hall and helped to establish the Cancer Research Campaign (CRC) laboratories at the University of Dundee in Dundee, Scotland. With support from the University of Dundee and CRC, he founded Cyclacel Pharmaceuticals, where he helped to identify several oncology drug candidates currently under clinical development.

Former Job Title

Chief Scientist

Former Company

Singapore’s Agency for Science, Technology and Research (A*STAR)

Industry

Nonprofits

Company Headquarters

New York, NY

Company Description

The Ludwig Institute for Cancer Research is an international non-profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for patient benefit. Since its establishment in 1971, the Institute has expended more than $1.5 billion on cancer research.